Abstract
SUMMARY The past decade has witnessed an increasing awareness of older adolescents and young adults (AYAs) with acute lymphoblastic leukemia as a distinct group of patients, with outcomes historically inferior to those of younger children. Retrospective comparison studies of AYAs treated on pediatric or adult clinical trials have demonstrated significantly improved outcomes for AYAs treated in pediatric trials. These findings have spurred international interest in prospectively evaluating pediatric regimens in young adults, and early results from several of these trials are encouraging. Additional study dedicated to the leukemia biology and psychosocial factors unique to the AYA patient will add further insight and hopefully improve outcomes for AYAs with acute lymphoblastic leukemia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
